Canada defeats NAFTA claim over pharma patents
Zyprexa, one of the drugs at the centre of the dispute
Canada has defeated a US$374 million NAFTA claim brought by US drugmaker Eli Lilly over the revocation of two drug patents.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Subscribe now